Protalix BioTherapeutics (PLX) Shareholder's Equity (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Protalix BioTherapeutics | 164.49 Mn | 153.70 Mn | 29.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 39.39% |
| Dec 31, 2025 | -8.84% |
| Sep 30, 2025 | 6.02% |
| Jun 30, 2025 | 10.39% |
| Mar 31, 2025 | 4.62% |
| Dec 31, 2024 | 33.22% |
| Sep 30, 2024 | 13.49% |
| Jun 30, 2024 | -4.05% |
| Mar 31, 2024 | -11.27% |
| Dec 31, 2023 | -12.23% |
| Sep 30, 2023 | -1.93% |
| Jun 30, 2023 | 3,769.15% |
| Mar 31, 2023 | 109.47% |
| Dec 31, 2022 | 7.59% |
| Sep 30, 2022 | -16.43% |
| Jun 30, 2022 | -32.10% |
| Mar 31, 2022 | -24.02% |
| Dec 31, 2021 | -2,933.80% |
| Sep 30, 2021 | -94.45% |
| Jun 30, 2021 | -73.52% |
| Mar 31, 2021 | 153.65% |
| Dec 31, 2020 | 18.84% |
| Sep 30, 2020 | 4.17% |
| Jun 30, 2020 | -12.57% |
| Mar 31, 2020 | 56.09% |
| Dec 31, 2019 | 0.74% |
| Sep 30, 2019 | -4.98% |
| Jun 30, 2019 | -12.75% |
| Mar 31, 2019 | -13.19% |
| Dec 31, 2018 | -10.30% |
| Sep 30, 2018 | -12.17% |
| Jun 30, 2018 | -20.60% |
| Mar 31, 2018 | -20.32% |
| Dec 31, 2017 | -12.99% |
| Sep 30, 2017 | -26.14% |
| Jun 30, 2017 | 69.81% |
| Mar 31, 2017 | -587.66% |
| Dec 31, 2016 | 34.07% |
| Sep 30, 2016 | -89.36% |
| Jun 30, 2016 | -400.98% |
| Mar 31, 2016 | -75.63% |
| Dec 31, 2015 | 115.87% |
| Sep 30, 2015 | -5.18% |
| Jun 30, 2015 | -6.51% |
| Mar 31, 2015 | -9.99% |
| Mar 31, 2014 | -24.61% |
| Dec 31, 2013 | -61.30% |
| Sep 30, 2013 | -39.38% |
| Jun 30, 2013 | -90.77% |
| Mar 31, 2013 | -87.16% |
| Dec 31, 2012 | -170.35% |
| Sep 30, 2012 | -39.31% |
| Jun 30, 2012 | 221.77% |
| Mar 31, 2012 | 75.24% |
| Dec 31, 2011 | -50.27% |
| Sep 30, 2011 | -99.39% |
| Jun 30, 2011 | -284.97% |
| Mar 31, 2011 | 141.55% |
| Dec 31, 2010 | -219.77% |
| Sep 30, 2010 | -127.86% |